title: Iontophoretic transport of charged macromolecules across human sclera.
abstract: The mechanisms of transscleral iontophoresis have been investigated previously with small molecules in rabbit sclera. The objective of the present study was to examine transscleral iontophoretic transport of charged macromolecules across excised human sclera. Passive and 2mA iontophoretic transport experiments were conducted in side-by-side diffusion cells with human sclera. The effects of iontophoresis upon transscleral transport of model permeants bovine serum albumin (BSA) and polystyrene sulfonic acid (PSS) as well as a model drug bevacizumab (BEV) were determined. Passive and iontophoretic transport experiments of tetraethylammonium (TEA) and salicylic acid (SA) and passive transport experiments of the macromolecules served as the controls. The results of iontophoresis enhanced transport of TEA and SA across human sclera were consistent with those in a previous rabbit sclera study. For the iontophoretic transport of macromolecules BSA and BEV, higher iontophoretic fluxes were observed in anodal iontophoresis as compared to passive and cathodal iontophoresis. This suggests the importance of electroosmosis. For the polyelectrolyte PSS, higher iontophoretic flux was observed in cathodal iontophoresis compared to anodal iontophoresis. Both electroosmosis and electrophoresis affected iontophoretic fluxes of the macromolecules; the relative contributions of electroosmosis and electrophoresis were a function of molecular size and charge of the macromolecules.
authors.affiliation: Division of Pharmaceutical Sciences, James L. Winkle College of Pharmacy, University of Cincinnati, Cincinnati, OH 45267, USA.
authors.forename: Poonam
authors.initials: P
authors.lastname: Chopra
authors.forename: Jinsong
authors.initials: J
authors.lastname: Hao
authors.forename: S Kevin
authors.initials: SK
authors.lastname: Li
mesh_terms: D000287:Administration, Topical; D000818:Animals; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000493:pharmacokinetics*; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D001692:Biological Transport; D002417:Cattle; D053841:Electroosmosis; D004586:Electrophoresis; D006801:Humans; D007478:Iontophoresis; D011137:Polystyrenes / Q000008:administration & dosage / Q000493:pharmacokinetics; D011817:Rabbits; D020156:Salicylic Acid / Q000008:administration & dosage / Q000493:pharmacokinetics; D012590:Sclera / Q000378:metabolism*; D012710:Serum Albumin, Bovine / Q000008:administration & dosage / Q000493:pharmacokinetics*; D019789:Tetraethylammonium / Q000008:administration & dosage / Q000493:pharmacokinetics
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D011137:Polystyrenes; D012710:Serum Albumin, Bovine; D000068258:Bevacizumab; D019789:Tetraethylammonium; C003321:polystyrene sulfonic acid; D020156:Salicylic Acid